Mast cells and their mediators in cutaneous wound healing - Active participants or innocent bystanders?

Experimental Dermatology

Volumn 8, Issue 1, 1999, Pages 1-16

  Artuc, M ^a   Hermes, B ^b   Steckelings, U M ^a   Grutzkau A ^a   Henz, B M ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angiogenesis; Fibroblasts; Keratinocytes; Mast cells; Wound healing

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 4; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE C4; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; EFFECTOR CELL; EPITHELIZATION; FIBROBLAST; GRANULATION TISSUE; HEMOSTASIS; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; KERATINOCYTE; LAMINA PROPRIA; MAST CELL; MEDIATOR RELEASE; MONONUCLEAR CELL; REVIEW; TISSUE REGENERATION; WOUND HEALING;

EID: 0032938967     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1999.tb00342.x     Document Type: Review

References (195)

1. Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki B M. Mast cells. Int J Dermatol 1995: 34: 1-10.
2. Czarnetzki B M, Grabbe J, Kolde G, Krüger-Krasagakes S, Welker P, Zuberbier T. Mast cells in the cytokine network: the what, where from and what for. Exp Dermatol 1995: 4: 221-226.
3. Lippert U, Artuc M, Grützkau A et al. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol, in press.
4. Nilsson G, Forsbergnilsson K, Yiang Z, Hallbook F, Nilsson K, Metcalfe DD. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997: 27: 2295-2301.
5. Christensen L, Simonsen A C W, Heegaard C W, Moestrup S K, Andersen J A, Andreasen P A. Immunohistochemical localization of urokinase type plasminogen activator, type 1 plasminogen activator inhibitor, urokinase receptor and alpha (2) macroglobulin receptor in human breast carcinomas. Int J Cancer 1996: 66: 441-452.
6. Sillaber C, Baghestanian M, Hofbauser R et al. Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem 1997: 272: 7824-7832.
7. Möller A, Henz B M, Grützkau A et al. Comparative cytokine gene expression, regulation and release by human mast cells. Immunology 1998: 93: 289-295.
8. + T lymphocyte chemoattractant factor, IL-16. J Immunol 1997: 159: 2904-2910.
9. Grabbe J, Welker P, Grützkau A et al. Induction of human leukemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor. Scand J Immunol 1998: 47: 324-331.
10. Nilsson G, Butterfield J H, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994: 153: 3717-3723.
11. Hartmann K, Henz B M, Krüger-Krasagakes S et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997: 89: 2863-2870.
12. Persinger M A, LePage P, Simard J P. Mast cell numbers, in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 1983: 108: 179-187.
13. Atkins F M, Clark R A F. Mast cells and fibrosis. Arch Dermatol 1987: 123: 191-193.
14. Seibold J R, Giorno R C, Claman H N. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990: 33: 1702-1709.
15. Levi-Schaffer F, Rubinchik E. Activated mast cells are fibrogenic for 3T3 fibroblasts. J Invest Dermatol 1995: 104: 999-1003.
16. Claman H N. Mast cells and fibrosis. The relevance to scleroderma. Rheum Dis Clin N Am 1990: 16: 141-151.
17. Hebda P A, Collins M A, Tharp M D Mast cell and myo-fibroblast in wound healing. Dermatol Clin 1993: 11: 685-696.
18. Wichmann B E. The mast cell count during the process of wound healing: an experimental investigation on rats. Acta Pathol Microbiol Scand 1955: 108: 1-35.
19. Haas N, Hamann K, Grabbe J, Cremer B, Czarnetzki B M. Expression of the high affinity IgE receptor on human Langerhans cells. Acta Derm Venereol (Stockh) 1992: 72: 271-272.
20. Maurer D, Fiebiger E, Reininger B et al. Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J Exp Med 1994: 179: 745-750.
21. Greenberg G, Burnstock G. A novel cell-to-cell interaction between mast cells and other cell types. Exp Cell Res 1983: 147: 1-13.
22. Galli S J. New insights into "The riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990: 62: 5-33.
23. Harvima I T, Horsmanheimo L, Naukkarinen A, Horsmanheimo M. Mast cell proteinases and cytokines in skin inflammation. Arch Dermatol Res 1994: 287: 61-67.
24. Irani A M A, Schwartz L B. Mast cell heterogeneity. Clin Exp Allergy 1989: 19: 143-155.
25. Algermissen B, Bauer F, Schadendorf D, Kropp J D, Czarnetzki B M. Analysis of mast cell subpopulations (MCT, MCTC) in cutaneous inflammation using novel enzyme-histochemical staining techniques. Exp Dermatol 1994: 3: 290-297.
26. Harvima I T, Naukkarinen A, Harvima R J, Aalto M L, Neittaanmäki H, Horsmanheimo M. Quantitative enzyme-histochemical analysis of tryptase- and chymase-7 containing mast cells in psoriatic skin. Arch Dermatol Res 1990: 282: 428-433.
27. Irani A A, Schlechter N M, Craig S S, DeBlois G, Schwartz L B. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986: 83: 4464-4468.
28. Nadel J A. Biology of mast cell tryptase and chymase. Ann N Y Acad Sci 1991: 629: 319-331.
29. Irani A M A, Gruber B L, Kaufman L D, Kahaleh M B, Schwartz L B. Mast cell changes in scleroderma. Arthritis Rheum 1992: 35: 933-939.
30. Hermes B, Feldmann-Böddeker I, Krüger-Krasagakes S, Henz B M. Mast cells express NGF- and GM-CSF-receptors. Comparison of normal versus scar tissue. Arch Derm Res 1997: 289: A40.
31. Furie B, Furie B C. The molecular basis of blood coagulation. Cell 1988: 53: 505-518.
32. Werb Z, Banda M J, Jones P A. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med 1980: 152: 1340-1357.
33. Kähäri V M, Saarialho-Kere U. Matrix metalloproteinases in the skin. Exp Dermatol 1997: 6: 199-213.
34. Chapman H A, Stone Jr O L. Cooperation between plasmin and elastase in elastin degradation by intact murine macrophages. Biochem J 1984: 222: 721-728.
35. Colman R W. Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun 1969: 35: 273-279.
36. Bouma B N, Griffin J H. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma. J Lab Clin Med 1978: 91: 148-155.
37. Nielsen L S, Kellerman G M, Behrendt N, Picone R, Dano K, Blasi F. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator: Identification in human tumor cell lines and partial purification. J Biol Chem 1988: 263: 2358-2363.
38. Cubellis M V, Nolli M L, Cassani G, Blasi F. Binding of a single chain pro-urokinase to the urokinase receptor of human U937 cells. J Biol Chem 1986: 261: 15819-15822.
39. Stacks M S, Johnson D A. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 1994: 269: 9416-9419.
40. Harvima I T, Harvima R J, Pentilla I M, Eloranta T O, Horsmanheimo M, Fraki J E. Effect of human mast cell tryptase on human plasma proenzymes. Int Arch Allergy Appl Immunol 1989: 90: 104-108.
41. Schwartz L B, Bradford T R, Littman B H, Wintroub B U. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 1985: 135: 2762-2767.
42. Loskutoff D J, Edgington T S. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA 1977: 74: 3903-3907.
43. Kawano T, Morimoto K, Uemura Y. Partial purification and properties of urokinase inhibitor from human placenta. J Biochem 1970: 67: 333-342.
44. Schaefer B M, Maier K, Eickhoh U, Bechtel M, Kramer M D. Alpha(2) antiplasmin and plasminogen activator inhibitors in healing human skin wounds. Arch Dermatol Res 1996: 288: 122-128.
45. Bajer J B, Low D A, Simmer R L, Cunningham D D. Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980: 21: 37-45.
46. Stimler N P, Bach M K, Bloor C M, Hugli T E. Release of leukotrienes from guinea pig lung stimulated by C5a des arg anaphylatoxin. J Immunol 1982: 128: 2247-2257.
47. Sueki H, Whitaker D, Buchsbaum M, Murphy G F. Novel interactions between dermal dendrocytes and mast cells in human skin. Implications for hemostasis and matrix repair. Lab Invest 1993: 69: 160-172.
48. Ciano P S, Colvin R B, Dvorak A M, McDonagh J, Dvorak H F. Macrophage migration in fibrin gel matrices. Lab Invest 1986: 54: 62-70.
49. Knox P, Crooks S, Rimmer C S. Role of fibronectin in the migration of fibroblasts into plasma clots. J Cell Biol 1986: 102: 2318-2323.
50. Bolton L L, Montagna W. Mast cells in human ulcers. Am J Dermatopathol 1993: 15: 133-138.
51. Clark R A F. Wound repair: Overview and general considerations. In: Clark R A F, ed. The molecular and cellular biology of wound repair (2nd edition). New York: Plenum Press, 1996: 3-35.
52. Mignatti P, Rifkin D B, Welgus H G, Parks W C. Proteinases and tissue remodeling. In: Clark R A F, ed. The molecular and cellular biology of wound repair (2nd edition). New York: Plenum Press, 1996: 427-461.
53. Grondahl-Hansen J, Lund L R, Ralfkiaer E, Ottevanger V, Dano K. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol 1988: 90: 790-795.
54. Bechtel M J, Reinartz J, Rox J M, Inndorf S, Schaefer B M, Kramer M D. Upregulation of cell surface associated plasminogen activation in cultured keratinocytes by interleukin 1 beta and tumor necrosis factor alpha. Exp Cell Res 1996: 223: 395-404.
55. McNeill H, Jensen P J. A high affinity receptor for urokinase plasminogen activator on human keratinocytes: Characterization and potential modulation during migration. Cell Regul 1990: 1: 843-852.
56. Estreicher A, Mühlhauser J, Carpentier J L, Orci L, Vassalli J D. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme-inhibitor complexes. J Cell Biol 1990: 111: 783-792.
57. Pollack R, Rifkin D B. Actin-containing cables within anchorage-dependent rat embryo cells are dissociated by plasmin and trypsin. Cell 1975: 495-506.
58. Fibbi G, Ziehe M, Morbidelli L, Magnelli L, Del Rosso M. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res 1988:179: 385-395 [published erratum in Exp Cell Res 186: 196].
59. Odekon L E, Sato Y, Rifkin D B. Urokinase-type plasminogen activator mediates basic fibroblasts growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 1992: 150: 258-263.
60. Pepper M S, Montesano R. Proteolytic balance and capillary morphogenesis. Cell Differ Dev 1990: 32: 319-328.
61. Alessandri G, Rajn K, Gullino P M. Mobilization of capillary endothelium in vitro induced by effectors of angio-genesis in vivo. Cancer Res 1983: 43: 1790-1797.
62. Bowesox J C, Sorgente N. Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res 1982: 42: 2547-2551.
63. Saksela O, Moscatelli D, Rifkin D B. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 1987: 105: 957-963.
64. Pepper M S, Sappino A P, Montesano R, Orci L, Vassalli J D. Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J Cell Physiol 1992: 153: 129-139.
65. Pepper M S, Sappino A P, Stocklin R, Montesano R, Orci L, Vassalli J D. Up-regulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993: 122: 673-684.
66. Tsuboi R, Sato Y, Rifkin D B. Correlation of cell migration, cell invasion, receptor number, proteinase production and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 1990: 110: 511-517.
67. Montesano R, Pepper M S, Mohle-Steinlen U, Risau W, Wagner E F, Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 1990: 62: 435-445.
68. Qu Z, Liebler J M, Powers M R et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995: 147: 564-573.
69. Nilsson G, Svensson V, Nilsson K. Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand J Immunol 1995: 42: 76-81.
70. Matrisian L M. The matrix-degrading metalloproteinases. Bioessays 1992: 14: 455-463.
71. Hatamochi A, Ueki H, Mauch C, Krieg T. Effect of histamine on collagen and collagen mRNA production in human skin fibroblasts. J Dermatol Sci 1991: 2: 407-410.
72. Isseroff R R, Fusenig F E, Rifkin D B. Plasminogen activator in differentiating mouse keratinocytes. J Invest Dermatol 1983: 80: 217-222.
73. Algermissen B. Die Mastzellproteasen Tryptase und Chymase: Vorkommen und potentielle modulatorische Wirkungen in entzündlichen Dermatosen. Inaugural Dissertation. Free University, Berlin, 1994.
74. Deuel T F, Kawahara R S, Musteo T A, Pierce A F. Growth factors and wound healing: Platelet-derived growth factor as a model cytokine. Annu Rev Med 1991: 42: 567-584.
75. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. Annu Rev Med 1994: 55: 410-422.
76. Eady R A, Cowen T, Marshall T F, Plummer V, Greaves M W. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 1979: 100: 623-633.
77. Watanabe Y, Lee S W, Detmar M, Ajioka I, Dvorak H F. Vascular permeability factor vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 1997: 14: 2025-2032.
78. Yamaguchi H, Ishii E, Saito S et al. Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Haematol 1996: 94: 606-611.
79. Grabbe J, Welker P, Rosenbach T et al. Release of stem cell factor (SCF) from human keratinocytes (HaCaT) is increased in differentiating versus proliferating cells. J Invest Dermatol 1996: 107: 219-224.
80. Meininger C J, Brightman S E, Kelly K A, Zetter B R. Increased stem cell factor release by hemangioma-derived endothelial cells. Lab Invest 1995: 72: 48-52.
81. Nilsson G, Butterfield J H, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994: 153: 3717-3723.
82. Schubert C, Christophers E. Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 1985: 277: 352-358.
83. Atkinson J B, Harlan C W, Harlan G C, Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994: 25: 154-159.
84. Mican J M, Metcalfe D D. Arthritis and mast cell activation. J Allergy Clin Immunol 1990: 86: 677-683.
85. Dimitriadou V, Koutsilieris M. Mast cell tumor cell interactions: for or against tumour growth and metastasis. Anticancer Res 1997: 17: 1541-1549.
86. Starkey J R, Crowle P K, Taubenberger S. Mast-cell-deficient W/W mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 1988: 42: 48-52.
87. Dethlefsen S M, Matsuura N, Zetter B R. Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis 1994-95: 14: 395-408.
88. Kischer C W, Bunce H, Shetlah M R. Mast cell analyses in hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 1978: 70: 355-357.
89. Matsuda H, Kitamura Y. Migration of stromal cells supporting mast-cell differentiation into open wound produced in the skin of mice. Exp Hematol 1981: 9: 38-43.
90. Trabbucchi E, Radaelli E, Marazzi M et al. The role of mast cells in wound healing. Int J Tissue React 1988: 10: 367-372.
91. Mucha K H, Huffman J E. Inflammatory cell stimulation and wound healing in Sphaeridiotrema globulus experimentally infected mallard ducks (Anas platyrhynchos). J Wildl Dis 1991: 27: 428-434.
92. Hebda P A, Collins M A, Tharp M D. Mast cell and myo-fibroblast in wound healing. Dermatol Clin 1993: 11: 685-696.
93. Liebler J M, Picou M A, Qu Z, Powers M R, Rosenbaum J T. Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin-induced lung injury. Growth Factors 1997: 14: 25-38.
94. Murata M, Hara K, Saku T. Dynamic distribution of basic fibroblast growth factor during epulus formation: an immunohistochemical study in an enhanced healing process of the gingiva. J Oral Pathol Med 1997: 26: 224-232.
95. Möller A, Lippert U, Lessmann D et al. Human mast cells produce IL-8. J Immunol 1993: 151: 3261-3266.
96. Gordon J R, Galli S J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990: 346: 274-276.
97. 206. Mol Biol Cell 1998: 875-884.
98. Dvorak A M, Kissell S. Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ. J Leukoc Biol 1991: 49: 197-210.
99. Nanney L B, Mueller S G, Bueno R. Peiper S C, Richmond A. Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair. Am J Pathol 1995: 147: 1248-1260.
100. Fahey T J, Sherry B, Tracey K J et al. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine 1990: 2: 92-99.
101. Montrucchio G, Lupia E, Battaglia E et al. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994: 180: 377-382.
102. Petzelbauer P, Watson C A, Pfau S E, Pober J S. IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995: 7: 267-272.
103. Yoshida S, Ono M, Shono T et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997: 17: 4015-4023.
104. Fajardo L F, Kwan H H, Kowalski J, Prionas S D, Allison A C. Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 1992: 140: 539-544.
105. Gruber B L, Schwartz L B, Ramamurthy N S, Irani A M, Marchese M J. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J Immunol 1988: 140: 3936-3942.
106. Taipale J, Lohi J, Saarinen J, Kovanen P T, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995: 270: 4689-4696.
107. Gruber B L, Marchese M J, Suzuki et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989: 84: 1657-1662.
108. Lees M, Taylor D J, Wooley D E. Mast cell proteinases activate precursors forms of collagenase and stromelysin, but not of gelatinase A and B. Eur J Biochem 1994: 223: 171-177.
109. Saarinen J, Kalkkinen N, Welgus H G, Kovanen P T. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond mast cell chymase. J Biol Chem 1994: 269: 18134-18140.
110. Blair R J, Meng H, Marchese M J et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997: 99: 2691-2700.
111. Kessler D A, Langer R S, Pless N A, Folkman J. Mast cells and tumor angiogenesis. Int J Cancer 1976: 18: 703-709.
112. Marks R M, Roche W R, Czerniecki M, Penny R, Nelson D S. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 1986: 55: 289-294.
113. Yayon A, Klagsbrun M, Esko J D, Leder R Ornitz D M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991: 64: 841-848.
114. Gitay-Goren H, Soker S, Vlodavsky W, Neufeld G. The binding of vascular endothelial growth factor to its receptor is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992: 267: 6093-6098.
115. Sakai K, Ren S L, Schwartz L B. A novel heparin dependent processing pathway for human tryptase: autocatalysis followed by activation with dipeptidyl peptidase 1. J Clin Invest 1996: 97: 988-995.
116. Reed J A, Albino A P, McNutt N S. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995: 72: 215-222.
117. Yayon A, Klagsbrun M, Esko J D. Leder P, Ornitz D M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991: 64: 841-848.
118. Maccarana M, Casu B, Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 1993: 268: 23898-23905.
119. Joseph-Silverstein J, Rifkin D B. Endothelial cell growth factors and the vessel wall. Semin Thromb Hemost 1987: 13: 504-513.
120. Han-Zhang X, Kepley C L, Sakai K, Chelliah J, Irani A M, Schwartz L B. Quantitation of tryptase, chymase, FcεRIα, and FcεRIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 1995: 154: 5472-5479.
121. Levi-Schaffer F, Kupietzky A. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp Cell Res 1990: 188: 42-49.
122. Ruoss S J, Hartmann T, Caughey G H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991: 88: 493-499.
123. Levi-Schaffer F, Rubinchik E. Activated mast cells are fibrogenic for 3T3 fibroblasts. J Invest Dermatol 1995: 104: 999-1003.
124. Schwartz LB. Tryptase, a mediator of human mast cells. J Allergy Clin Immunol 1990: 86: 594-598.
125. Gruber B L, Schwartz L B. The mast cell as an effector of connective tissue degradation: a study of matrix susceptibility to human mast cells. Biochem Biophys Res Commun 1990: 171: 1272-1278.
126. Harvima I T, Horsmanheimo L, Naukkarinen A, Horsmanheimo M. Mast cell proteinases and cytokines in skin inflammation. Arch Dermatol Res 1994: 287: 61-67.
127. Caughey GH, Zerweck EH. Vanderslice P. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem 1991: 266: 12956-12963.
128. Tharp MD, Carrozza M, Schlechter N et al. Mast cell chymase induces keratinocyte and fibroblast injury. J Invest Dermatol 1992: 98: 594-599.
129. Sanker S, Chandrasekharan U M, Wiik D, Glynias M J, Karnik S S, Husain A. Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation. J Biol Chem 1997: 272: 2963-2968.
130. 2 angiotensin receptor. Biochem Biophys Res Commun 1996: 229: 329-333.
131. Di Marco E, Marchisio P C, Bondanza S, Franzi A T, Cancedda R, De Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991: 266: 21718-21722.
132. Li A K C, Koroly M J, Schattenkerk M E, Malt R A, Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci 1980: 77: 4379-4381.
133. Pincelli C, Sevignani C, Manfredini C et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994: 103: 13-18.
134. Tron V A, Coughlin M D, Jang D E, Stanisz J, Sauder D N. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990: 85: 1084-1089.
135. Yaar M, Grosman K, Eller M. Gilchrest B A. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biology 1991: 115: 821-828.
136. Hutson J M, Niall M, Evans D, Fowler R. Effect of salivary glands on wound contraction in mice. Nature 1979: 279: 793-795.
137. Marshal J S, Stead R H, McSharry C Nielsen L, Schwartz J B. The role of mast cell degranulation products in mast cell hyperplasia. J Immunology 1990: 144: 1866-1892.
138. Kawamoto K, Okada T, Kannan Y, Ushio H, Matsumoto M, Matsuda H. Nerve growth factor prevents apoptosis of rat peritoneal cells through the trk proto-oncogene receptor. Blood 1995: 86: 4638-4644.
139. Wilkinson D I, Theeuwes M J, Farber E M. Nerve growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes: a comparison with epidermal growth factor. Exp Dermatol 1994: 3: 239-245.
140. Di Marco E, Mathor M, Bondanza S et al. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 1993: 268: 22838-22846.
141. Fantini F, Johansson O. Expression of growth-associated protein 43 and nerve growth factor receptor in human skin: a comparative immunohistochemical investigation. J Invest Dermatol 1992: 99: 734-742.
142. Bothwell M. Tissue localization of nerve growth factor and nerve growth factor receptors. CTMI 1991: 165: 55-70.
143. DeKosky S T, Styren S D, O'Malley M E et al. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann Neurol 1996: 39: 123-127.
144. Matsuda H, Kannan Y, Ushio H et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991: 174: 7-14.
145. Pearce F L, Thompson H L. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 1986: 372: 379-393.
146. Welker P, Grabbe J, Grützkau A, Henz B M. Effects of NGF and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology, in press.
147. Fantini F, Gianetti A, Benassi L, Cattaneo V, Magnoni C, Pincelli C. Nerve growth factor receptor and neurochemical markers in human oral mucosa: an immunohistochemical study. Dermatology 1995: 190: 186-191.
148. Lee K F, Li E, Huber L J et al. Targeted mutation of the gene encoding the low affinity nerve growth factor receptor p 75 leads to deficits in the: peripheral sensory nervous system. Cell 1992: 69: 737-749.
149. Ribeiro-Da-Silva A, Kenigsberg R L, Cuello A C. Sight and electron microscopic distribution of nerve growth factor receptor-like immunoreactivity in the skin of the rat lower lip. Neuroscience 1991: 43: 631-646.
150. Yaar M, Eller M S, DiBenedetto P et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 1994: 94: 1550-1562.
151. Klein R, Jing S, Nanduri V, O'Rourke E, Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor receptor. Cell 1991: 65: 189-197.
152. Hempstead B L, Martin-Zanca D, Kaplan D R, Parada L F, Chao M V. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991: 350: 678-683.
153. Cordon-Cardo C, Tapley P, Jing S et al. The trk tyrosine protein kinase mediates the rr itogenic properties of nerve growth factor and neurotrophin-3. Cell 1991: 66: 173-183.
154. Grabbe J, Welker P, Dippel E, Czarnetzki B M. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994: 287: 78-84.
155. Weiss R R, Whitaker-Menezes D, Longley J, Bender J, Murphy G F. Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 1995: 104: 101-106.
156. Rennick D, Hunte B, Holland G, Thompson-Snipes L. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-IO, and fibroblasts. Blood 1995: 85: 57-65.
157. Tsai M, Takeishi T, Thompson H et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the c-kit ligand, stem cell factor. Proc Natl Acad Sci 1991: 88: 6382-6386.
158. Grabarek J, Groopman J E, Lyles Y R et al. Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem 169: 21718-21724.
159. Antoniades H N, Scher C D, Stiles C D. Purification of human platelet-derived factor. Proc Nat Acad Sci USA 1979: 76: 1809-1812.
160. Hammacher A, Hellman U, Johnsson A et al. A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem 1988: 263: 16493-16498.
161. Wennström S, Hawkins P, Cooke F et al. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol 1994: 4: 385-393.
162. Helin C H, Westermark B. Platelet-derived growth factor: Mechanism of action and possible in vivo function. Cell Regul 1990: 1: 555-566.
163. Seppä H, Grotendorst G, Seppä S, Schiefmann E, Martin G R. Platelet derived growth factor is chemotactic for fibroblasts. J Cell Biol 1990: 92: 584-588.
164. Heldin P, Laurent T C, Heldin C H. Effect of growth factors on hyaluronon synthesis in cultured human fibroblast. Biochem J 1989: 258: 919-922.
165. Blatti S P, Forster A, Heldin C H, Westermark B. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci USA 1988: 85: 1119-1123.
166. Sato N, Beitz J G, Kato J et al. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993: 142: 1119-1130.
167. Shimokado K, Raines E W, Madtes D K, Barrett T B, Benditt E P, Ross R. A significant part of macrophage-derived growth factor consist of at least two forms of PDGF. Cell 1995: 43: 277-286.
168. Bauer E A, Cooper T W, Huang J S, Altmann J, Deuel T F. Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci USA 1985: 82: 4132-4136.
169. Brem H, Klagsburn M. The role of fibroblast growth factors and related oncogenes in tumor growth, in: Oncogenes and tumor suppressor genes in human malignancies. Boston: Kluver Academic Publishers, 1993: 211-231.
170. Miyomoto M, Naruo K I, Seko C, Matsumoto S, Kondo T, Kurakawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion properly. Mol Cell Biol 1993: 13: 123-130.
171. Burgess W, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989: 58: 575-606.
172. Sato Y, Rifkin D B. Autocrine activities of basic fibroblast growth factor. Regulation of endothelial cell movement, plasminoogen activator synthesis, and DNA synthesis. J Cell Biol 1988: 107: 1199-1205.
173. Reed J A, Albino A P, McNutt N S. Human cutaneous mast cells express basic tibroblast growth factor. Lab Invest 1995: 72: 215-222.
174. Inoue Y, King T E, Tinkle S S, Dockstader K, Newman L S. Human mast cell basic fibroblast growth factor in pulmonary fibrolic disorders. Am J Path 1996: 149: 2037-2054.
175. Friedl L, Chang Z, Tierney A, Rapraeger A C. Differential binding of fibroblast growth factor 2 and 7 to basement membrane heparan sulfate. Comparison of normal and abnormal human tissues. Am J Path 1997: 150: 1443-1455.
176. Gao G, Goldfarb M. Heparin can activate a receptor tyrosine kinase. EMBO J 1995: 14: 2183-2190.
177. Klangsburn M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991: 67: 1-20.
178. Imaizumi T, Louis J, Bailly C, Cicurel L, Petchot J P, Dubertret L. Effect of human basic fibroblast growth factor on fibroblast proliferation, cell volume, collagen lattice contraction: in comparison with acidic type. J Dermatol Sci 1996: 11: 134-141.
179. Schreier T, Degen E, Baschong W. Fibroblast migration and proliferation during in vitro wound healing. Res Exp Med 1993: 193: 195-205.
180. Buckley A, Woodward S C, Senior S M, Griffin G L, Klagsburn M, Davidson J M. Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol 1989: 138: 70-78.
181. Mignetti P, Tsuboi R, Robbins W, Rifkin D B. In vitro angiogenesis on the human amniotic membrane. Requirement for basic fibroblast growth factor induced proteinases. J Cell Biol 1989: 108: 671-682.
182. Longaker M T, Bouhana K S. Harrison M R, Danielpour D, Roberts A B, Banda M J. Wound healing in the fetus. Possible role for inflammatory macrophages and transforming growth factor-β isoforms. Wound Rep Reg 1994: 2: 104-112.
183. Miyazono K, Ichijo H, Heldin H C. Transforming growth factor: Latent forms, binding proteins and receptors. Growth Factors 1993: 8: 11-22.
184. 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995: 270: 4689-4696.
185. Brown G L, Curtsinger L J, White M et al. Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann Surg 1988: 208: 788-794.
186. Bonewald L F, Wakefield L, Oreffo R O C, Oscebado A, Twardzik D R, Mundy G R. Latent forms of transforming growth factor β derived from bone cultures: Identification of a naturally occurring 100 kDa complex with similarity to recombinant latent TGF-β. Mol Endocrinol 1991: 5: 741-751.
187. Bornstein P. Thrombospondins-structure and regulation of the expression. FASEB J 1992: 6: 3290-3299.
188. Hebda P A. Stimulatory effects of transforming growth factor-β and epidermal growth factor on epidermal cell outgrowth from porcine skin expiant cultures. J Invest Dermatol 1988: 91: 440-445.
189. Ellis I, Grey A M, Schor A M. Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing. J Cell Sci 1992: 102: 447-456.
190. Wahl S, Hunt D A, Wakefield L M et al. Transforming growth factor type beta induces monocytes chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987: 84: 5788-5792.
191. Adams D H, Hathaway M, Shaw J, Burnett D, Elias E, Strain A J. Transforming growth factor-beta induces human T lymphocyte migration in vitro. J Immunol 1991: 147: 609-612.
192. 1 mediates mast cell chemotaxis. J Immunol 1994: 152: 5860-5867.
193. Philipps G D, Whitead R A, Knighton D R. Inhibition by methylprednisolone acetate suggests an indirect mechanism for TGF-β induced angiogenesis. Growth Factors 1992: 6: 77-84.
194. Pepper M S, Vassalli J D, Orci L, Montesano R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 1993: 204: 356-363.
195. Hartmann K, Wagelie-Steffen A L, von Stebut E, Metcalfe D D. Fas (CD95, APO-1) antigen expression and function in murine mast cells. J Immunol 1997: 159: 4006-4016.